| Product Code: ETC9937502 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Alpha Emitter Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Alpha Emitter Market - Industry Life Cycle |
3.4 United Kingdom (UK) Alpha Emitter Market - Porter's Five Forces |
3.5 United Kingdom (UK) Alpha Emitter Market Revenues & Volume Share, By Type of Radionuclide, 2021 & 2031F |
3.6 United Kingdom (UK) Alpha Emitter Market Revenues & Volume Share, By Medical Application, 2021 & 2031F |
3.7 United Kingdom (UK) Alpha Emitter Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Alpha Emitter Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and rising demand for effective cancer treatments |
4.2.2 Technological advancements in alpha emitter therapy leading to improved treatment outcomes |
4.2.3 Growing investments in healthcare infrastructure and research development in the UK |
4.3 Market Restraints |
4.3.1 Stringent regulations and lengthy approval processes for alpha emitter therapies |
4.3.2 High costs associated with alpha emitter therapy development and treatment |
4.3.3 Limited awareness among healthcare providers and patients about the benefits of alpha emitter therapy |
5 United Kingdom (UK) Alpha Emitter Market Trends |
6 United Kingdom (UK) Alpha Emitter Market, By Types |
6.1 United Kingdom (UK) Alpha Emitter Market, By Type of Radionuclide |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, By Type of Radionuclide, 2021- 2031F |
6.1.3 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, By Astatine, 2021- 2031F |
6.1.4 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, By Radium, 2021- 2031F |
6.1.5 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, By Actinium, 2021- 2031F |
6.1.6 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, By Lead, 2021- 2031F |
6.1.7 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, By Bismuth, 2021- 2031F |
6.1.8 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Alpha Emitter Market, By Medical Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.3 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, By Bone Metastasis, 2021- 2031F |
6.2.4 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.2.5 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.2.6 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, By Endocrine Tumors, 2021- 2031F |
6.2.7 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Alpha Emitter Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, By Medical Research Institutions, 2021- 2031F |
6.3.4 United Kingdom (UK) Alpha Emitter Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Alpha Emitter Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Alpha Emitter Market Export to Major Countries |
7.2 United Kingdom (UK) Alpha Emitter Market Imports from Major Countries |
8 United Kingdom (UK) Alpha Emitter Market Key Performance Indicators |
8.1 Number of clinical trials and research studies focused on alpha emitter therapies in the UK |
8.2 Adoption rate of alpha emitter therapies among healthcare facilities and oncologists |
8.3 Percentage of healthcare budget allocated to nuclear medicine and targeted radionuclide therapy in the UK |
9 United Kingdom (UK) Alpha Emitter Market - Opportunity Assessment |
9.1 United Kingdom (UK) Alpha Emitter Market Opportunity Assessment, By Type of Radionuclide, 2021 & 2031F |
9.2 United Kingdom (UK) Alpha Emitter Market Opportunity Assessment, By Medical Application, 2021 & 2031F |
9.3 United Kingdom (UK) Alpha Emitter Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Alpha Emitter Market - Competitive Landscape |
10.1 United Kingdom (UK) Alpha Emitter Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Alpha Emitter Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here